The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Altered Tumor-Cell Glycosylation Promotes Metastasis
Open accessAbstract
Malignant transformation of cells is associated with aberrant glycosylation presented on the cell-surface. Commonly observed changes in glycan structures during malignancy encompass aberrant expression and glycosylation of mucins; abnormal branching of N-glycans; and increased presence of sialic acid on proteins and glycolipids. Accumulating evidence supports the notion that the presence of certain glycan structures correlates with cancer progression by affecting tumor-cell invasiveness, ability to disseminate through the blood circulation and to metastasize in distant organs. During metastasis tumor-cell-derived glycans enable binding to cells in their microenvironment including endothelium and blood constituents through glycan-binding receptors - lectins. In this review, we will discuss current concepts how tumor-cell-derived glycans contribute to metastasis with the focus on three types of lectins: siglecs, galectins, and selectins. Siglecs are present on virtually all hematopoietic cells and usually negatively regulate immune responses. Galectins are mostly expressed by tumor cells and support tumor-cell survival. Selectins are vascular adhesion receptors that promote tumor-cell dissemination. All lectins facilitate interactions within the tumor microenvironment and thereby promote cancer progression. The identification of mechanisms how tumor glycans contribute to metastasis may help to improve diagnosis, prognosis, and aid to develop clinical strategies to prevent metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Algebraic decay in hierarchical graphs
Garcia, A., Sonnino, G., Malek-Mansour, M.-A., & Baras, F. (1997) · doi:10.1023/a · Cited by 5,187
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2056 · Cited by 2,031
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Selectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
T and Tn, General Carcinoma Autoantigens
Springer, G. F. (1984) · Science · doi:10.1126/science.6729450 · Cited by 1,009
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., & Degen, J. L. (2005) · Blood · doi:10.1182/blood-2004-06-2272 · Cited by 999
β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis
Dennis, J. W., Laferté, S., Waghorne, C., Breitman, M. L., & Kerbel, R. S. (1987) · Science · doi:10.1126/science.2953071 · Cited by 940
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914
Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
Rabinovich, G. A., & Toscano, M. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2536 · Cited by 904
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Côté, D., Means, T. K., Luster, A. D., Scadden, D. T., & Lin, C. P. (2005) · Nature · doi:10.1038/nature03703 · Cited by 878
Trousseau's syndrome: multiple definitions and multiple mechanisms
Varki, A. (2007) · Blood · doi:10.1182/blood-2006-10-053736 · Cited by 840
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt, B., Hafner, M., Echtenacher, B., & Männel, D. N. (1999) · PubMed · Cited by 832
Hakomori, S. (1985) · PubMed · Cited by 804
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Self-citationQian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death
Perillo, N. L., Marcus, M. E., & Baum, L. G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050232 · Cited by 640
Petersdorf, S. H., Kopecky, K. J., Slovak, M., Willman, C., Nevill, T., Brandwein, J., Larson, R. A., Erba, H. P., Stiff, P. J., Stuart, R. K., et al. (2013) · Blood · doi:10.1182/blood-2013-01-466706 · Cited by 638
Multifarious roles of sialic acids in immunity
Varki, A., & Gagneux, P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06517.x · Cited by 611
Pathways of O-glycan biosynthesis in cancer cells
Brockhausen, I. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00170-1 · Cited by 583
Suppression of tumor growth and metastasis in Mgat5-deficient mice
Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., & Dennis, J. W. (2000) · Nature Medicine · doi:10.1038/73163 · Cited by 569
Perspectives on the significance of altered glycosylation of glycoproteins in cancer
Kim, Y. J., & Varki, A. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018580324971 · Cited by 535
Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00024-8 · Cited by 531
Diversity in cell surface sialic acid presentations: implications for biology and disease
Varki, N. M., & Varki, A. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700656 · Cited by 515
Mucin‐type O ‐glycans in human colon and breast cancer: glycodynamics and functions
Brockhausen, I. (2006) · EMBO reports · doi:10.1038/sj.embor.7400705 · Cited by 511
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
Itzkowitz, S., Yuan, M., Montgomery, C. K., Kjeldsen, T., Takahashi, H., Bigbee, W. L., & Kim, Y. S. (1989) · PubMed · Cited by 511
INFECTIOUS COMPLICATIONS IN PATIENTS WITH ACUTE PROMYELOCITIC LEUKEMIA TREATED WITH THE AIDA REGIMEN
C, G., M, B., La Tagliata, R., Spadea, A., D'Andrea, M., P, M., Lo‐Coco, F., Gentile, G., Micozzi, A., Alimena, G., et al. (2003) · IRIS Research product catalog (Sapienza University of Rome) · doi:10.1038/sj · Cited by 510
Ju, T., & Cummings, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262438199 · Cited by 487
Labelle, M., & Hynes, R. O. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0329 · Cited by 486
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Hudak, J. E., Canham, S. M., & Bertozzi, C. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1388 · Cited by 485
The selectins and their ligands
Rosen, S. D., & Bertozzi, C. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90092-2 · Cited by 470
Taylor-Papadimitriou, J., Burchell, J., Miles, D. W., & Dalziel, M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00055-1 · Cited by 465
Selectins promote tumor metastasis
Läubli, H., & Borsig, L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.005 · Cited by 461
Self-citationP-selectin deficiency attenuates tumor growth and metastasis
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9325 · Cited by 454
Self-citationNakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T., Iwanaga, T., Matsushita, Y., & Irimura, T. (1993) · PubMed · Cited by 425
Selectins: lectins that initiate cell adhesion under flow
McEver, R. P. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00367-8 · Cited by 413
Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261704098 · Cited by 400
Self-citationKung Sutherland, M. S., Walter, R. B., Jeffrey, S. C., Burke, P. J., Yu, C., Kostner, H., Stone, I., Ryan, M. C., Sussman, D., Lyon, R. P., et al. (2013) · Blood · doi:10.1182/blood-2013-03-491506 · Cited by 391
N-Glycans in cancer progression
Lau, K. S., & Dennis, J. W. (2008) · Glycobiology · doi:10.1093/glycob/cwn071 · Cited by 390
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
Camerer, E., Qazi, A. A., Duong, D. N., Cornelissen, I., Advincula, R., & Coughlin, S. R. (2004) · Blood · doi:10.1182/blood-2004-02-0434 · Cited by 386
The role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
Gil-Bernabé, A. M., Ferjančič, Š., Tlalka, M., Zhao, L., Allen, P. D., Im, J. H., Watson, K., Hill, S. A., Amirkhosravi, A., Francis, J. L., et al. (2012) · Blood · doi:10.1182/blood-2011-08-376426 · Cited by 352
Mechanisms Underlying Aberrant Glycosylation of MUC1 Mucin in Breast Cancer Cells
Brockhausen, I., Yang, J., Burchell, J., Whitehouse, C., & Taylor‐Papadimitriou, J. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.607_2.x · Cited by 346
Heider, K. H., Hofmann, M., Hors, E., van den Berg, F., Ponta, H., Herrlich, P., & Pals, S. T. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.1.227 · Cited by 342
Glycosylation, galectins and cellular signaling
Boscher, C., Dennis, J. W., & Nabi, I. R. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.05.001 · Cited by 341
Hofmann‐Apitius, M., Rudy, W., Zöller, M., Tölg, C., Ponta, H., Herrlich, P. A., & Günthert, U. (1991) · PubMed · doi:10.5451/unibas-ep6484 · Cited by 338
IL-18 regulates IL-1 β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
Vidal-Vanaclocha, F., Fantuzzi, G., Mendoza, L., Fuentes, A. M., Anasagasti, M. J., Martín, J., Carrascal, T., Walsh, P., Reznikov, L. L., Kim, S.-H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.734 · Cited by 338
CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells
Aigner, S., Sthoeger, Z. M., Fogel, M., Weber, E., Zarn, J., Ruppert, M., Zeller, Y., Vestweber, D., Stahel, R., Sammar, M., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3385 · Cited by 325
Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer
Kannagi, R. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018532409041 · Cited by 321
Takenaka, Y., Fukumori, T., & Raz, A. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014084.01324.15 · Cited by 321
Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318882 · Cited by 317
Self-citationSeales, E. C., Jurado, G. A., Brunson, B. A., Wakefield, J. K., Frost, A. R., & Bellis, S. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3117 · Cited by 317
Selectin ligands: will the real ones please stand up?
Varki, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119142 · Cited by 315
Glycosylation in immune cell trafficking
Sperandio, M., Gleissner, C. A., & Ley, K. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00795.x · Cited by 310
Kantarjian, H., Thomas, D., Jorgensen, J., Kebriaei, P., Jabbour, E., Rytting, M., York, S., Ravandi, F., Garris, R., Kwari, M., et al. (2013) · Cancer · doi:10.1002/cncr.28136 · Cited by 306
Regulation of the metastatic cell phenotype by sialylated glycans
Schultz, M. J., Swindall, A. F., & Bellis, S. L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9359-7 · Cited by 303
Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis
Nutku, E., Aizawa, H., Hudson, S. A., & Bochner, B. S. (2003) · Blood · doi:10.1182/blood-2002-10-3058 · Cited by 303
Mucins in pancreatic cancer and its microenvironment
Kaur, S., Kumar, S., Momi, N., Sasson, A. R., & Batra, S. K. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.120 · Cited by 301
Zhang, S., Zhang, H. S., Cordon-Cardo, C., Reuter, V. E., Singhal, A. K., Lloyd, K. O., & Livingston, P. O. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<50::aid-ijc9>3.0.co;2-0 · Cited by 299
Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., Willard, M. T., Wang, W., Xia, J. Y., Zuna, R. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2345 · Cited by 292
Mucin glycoproteins in neoplasia
Kim, Y. S., Gum, J., & Brockhausen, I. (1996) · Glycoconjugate Journal · doi:10.1007/bf00702333 · Cited by 291
Wolf, M. J., Hoos, A., Bauer, J., Boettcher, S., Knust, M., Weber, A., Simonavicius, N., Schneider, C., Lang, M., Stürzl, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.023 · Cited by 290
Self-citationPlatelets and cancer metastasis: A causal relationship?
Honn, K. V., Tang, D. G., & Crissman, J. D. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307186 · Cited by 289
(2002) · PubMed · Cited by 279
Glycobiology of immune responses
Rabinovich, G. A., van Kooyk, Y., & Cobb, B. A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06492.x · Cited by 279
Demetriou, M., Nabi, I. R., Coppolino, M., Dedhar, S., & Dennis, J. W. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.383 · Cited by 268
Role of Platelets in Tumor Cell Metastases
KARPATKIN, S., & PEARLSTEIN, E. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-5-636 · Cited by 266
Dalotto-Moreno, T., Croci, D. O., Cerliani, J. P., Martinez-Allo, V. C., Dergan-Dylon, S., Méndez-Huergo, S. P., Stupirski, J. C., Mazal, D., Osinaga, E., Toscano, M. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2418 · Cited by 261
Marcos, N. T., Pinho, S., Grandela, C., Cruz, A., Samyn-Petit, B., Harduin-Lepers, A., Almeida, R., Silva, F., Morais, V., Costa, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1921 · Cited by 258
Lu, X., & Kang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035899 · Cited by 257
Plasma membrane domain organization regulates EGFR signaling in tumor cells
Lajoie, P., Partridge, E. A., Guay, G., Goetz, J. G., Pawling, J., Lagana, A., Joshi, B., Dennis, J. W., & Nabi, I. R. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611106 · Cited by 253
Structure, evolution, and biology of the MUC4 mucin
Chaturvedi, P., Singh, A. P., & Batra, S. K. (2008) · The FASEB Journal · doi:10.1096/fj.07-9673rev · Cited by 252
Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins.
Mannori, G., Crottet, P., Cecconi, O., Hanasaki, K., Aruffo, A. A., Nelson, R. M., Varki, A. P., & Bevilacqua, M. P. (1995) · PubMed · Cited by 247
Mucins: Structure, function, and associations with malignancy
Devine, P. L., & McKenzie, I. F. C. (1992) · BioEssays · doi:10.1002/bies.950140909 · Cited by 247
Koike, T., Kimura, N., Miyazaki, K., Yabuta, T., Kumamoto, K., Takenoshita, S., Chen, J., Kobayashi, M., Hosokawa, M., Taniguchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402088101 · Cited by 245
Glinsky, V. V., Glinsky, G. V., Rittenhouse‐Olson, K., Huflejt, M. E., Glinskii, O. V., Deutscher, S. L., & Quinn, T. P. (2001) · PubMed · Cited by 239
P-selectin Glycoprotein Ligand-1 Mediates L-Selectin–dependent Leukocyte Rolling in Venules
Sperandio, M., Smith, M. L., Forlow, S. B., Olson, T. S., Xia, L., McEver, R. P., & Ley, K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021854 · Cited by 238
Kobata, A., & Amano, J. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01351.x · Cited by 237
McCarty, O. J. T., Mousa, S. A., Bray, P. F., & Konstantopoulos, K. (2000) · Blood · doi:10.1182/blood.v96.5.1789 · Cited by 223
Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis
Brodt, P., Fallavollita, L., Bresalier, R. S., Meterissian, S. H., Norton, C. R., & Wolitzky, B. A. (1997) · International Journal of Cancer · Cited by 223
O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy
Burchell, J. M., Mungul, A., & Taylor-Papadimitriou, J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011331809881 · Cited by 221
Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines
Burdick, M. D., Harris, A., Reid, C. J., Iwamura, T., & Hollingsworth, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24198 · Cited by 215
Amano, M., Galvan, M., He, J., & Baum, L. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209595200 · Cited by 212
Khaldoyanidi, S. K., Glinsky, V. V., Sikora, L., Glinskii, A. B., Mossine, V. V., Quinn, T. P., Glinsky, G. V., & Sriramarao, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209590200 · Cited by 211
Zhao, Q., Barclay, M., Hilkens, J., Guo, X., Barrow, H., Rhodes, J. M., & Yu, L.-G. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-154 · Cited by 209
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
Belisle, J. A., Horibata, S., Jennifer, G. A., Petrie, S., Kapur, A., André, S., Gabius, H.-J., Rancourt, C., Connor, J., Paulson, J. C., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-118 · Cited by 207
Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor Cells
Lagana, A., Goetz, J. G., Cheung, P., Raz, A., Dennis, J. W., & Nabi, I. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3181-3193.2006 · Cited by 207
Crocker, P. R., & Gordon, S. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.1862 · Cited by 206
Julien, S., Adriaenssens, E., Ottenberg, K., Furlan, A., Courtand, G., Vercoutter-Edouart, A.-S., Hanisch, F.-G., Delannoy, P., & Le Bourhis, X. (2006) · Glycobiology · doi:10.1093/glycob/cwj033 · Cited by 204
The role of platelet activation in tumor metastasis
Borsig, L. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.8.1247 · Cited by 199
Self-citationHiratsuka, S., Goel, S., Kamoun, W. S., Maru, Y., Fukumura, D., Duda, D. G., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100446108 · Cited by 196
Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis
Ludwig, R. J., Boehme, B., Podda, M., Henschler, R., Jager, E., Tandi, C., Boehncke, W.-H., Zollner, T. M., Kaufmann, R., & Gille, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1054 · Cited by 195
Khatib, A., Kontogiannea, M., Fallavollita, L., Jamison, B. M., Meterissian, S. H., & Brodt, P. (1999) · PubMed · Cited by 192
Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers
Julien, S., Ivetic, A., Grigoriadis, A., QiZe, D., Burford, B., Sproviero, D., Picco, G., Gillett, C., Papp, S. L., Schaffer, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1139 · Cited by 191
Bresalier, R. S., Niv, Y., Byrd, J. C., Duh, Q. Y., Toribara, N. W., Rockwell, R. W., Dahiya, R., & Kim, Y. S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115063 · Cited by 189
Kim, Y. J., Borsig, L., Han, H.-L., Varki, N. M., & Varki, A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65142-5 · Cited by 189
Self-citationTakamiya, R., Ohtsubo, K., Takamatsu, S., Taniguchi, N., & Angata, T. (2013) · Glycobiology · doi:10.1093/glycob/cws139 · Cited by 189
CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O -Glycans
Nguyen, J. T., Evans, D. P., Galvan, M., Pace, K. E., Leitenberg, D., Bui, T. N., & Baum, L. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5697 · Cited by 188
Siglecs as targets for therapy in immune-cell-mediated disease
O’Reilly, M. K., & Paulson, J. C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.005 · Cited by 187
Coupland, L. A., Chong, B. H., & Parish, C. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4010 · Cited by 186
Dalziel, M., Whitehouse, C., McFarlane, I., Brockhausen, I., Gschmeissner, S., Schwientek, T., Clausen, H., Burchell, J. M., & Taylor-Papadimitriou, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006523200 · Cited by 185
Zheng, M., Fang, H., & Hakomori, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32719-9 · Cited by 184
Uemura, T., Shiozaki, K., Yamaguchi, K., Miyazaki, S., Satomi, S., Kato, K., Sakuraba, H., & Miyagi, T. (2009) · Oncogene · doi:10.1038/onc.2008.471 · Cited by 184
An 2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas
Burchell, J., Poulsom, R., Hanby, A., Whitehouse, C., Cooper, L., Clausen, H., Miles, D., & Taylor-Papadimitriou, J. (1999) · Glycobiology · doi:10.1093/glycob/9.12.1307 · Cited by 180
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.
Stone, J. P., & Wagner, D. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116654 · Cited by 179
van den Brûle, F., Califice, S., Garnier, F., Fernandez, P. L., Berchuck, A., & Castronovo, V. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000059949.01480.40 · Cited by 176
Cooney, C. A., Jousheghany, F., Yao-Borengasser, A., Phanavanh, B., Gomes, T., Kieber-Emmons, A. M., Siegel, E. R., Suva, L. J., Ferrone, S., Kieber-Emmons, T., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2895 · Cited by 175
Monospecific and common glycoprotein ligands for E- and P-selectin on myeloid cells.
Lenter, M., Levinovitz, A., Isenmann, S., & Vestweber, D. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.471 · Cited by 171
Alterations of O-glycan biosynthesis in human colon cancer tissues
Yang, J.-M., Byrd, J. C., Siddiki, B. B., Chung, Y.-S., Okuno, M., Sowa, M., Kim, Y. S., Matta, K. L., & Brockhausen, I. (1994) · Glycobiology · doi:10.1093/glycob/4.6.873 · Cited by 169
Redirection of tumor metastasis by expression of E-selectin in vivo.
Biancone, L., Araki, M., Araki, K., Vassalli, P., & Stamenkovic, I. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.581 · Cited by 167
Shao, B., Wahrenbrock, M. G., Yao, L., David, T., Coughlin, S. R., Xia, L., Varki, A., & McEver, R. P. (2011) · Blood · doi:10.1182/blood-2011-07-368514 · Cited by 166
Läubli, H., Spanaus, K.-S., & Borsig, L. (2009) · Blood · doi:10.1182/blood-2008-10-186585 · Cited by 166
Self-citationCao, Y., Stosiek, P., Springer, G. F., & Karsten, U. (1996) · Histochemistry and Cell Biology · doi:10.1007/bf02484401 · Cited by 165
Manne, U., Myers, R. B., Moron, C., Poczatek, R. B., Dillard, S. C., Weiss, H. L., Brown, D., Srivastava, S., & Grizzle, W. E. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<296::aid-ijc11>3.0.co;2-a · Cited by 163
Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., Chen, M., An, Y., Wei, J., Zhu, Y., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26290 · Cited by 162
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O‐glycans
Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Yoneyama, T., Mori, K., Koie, T., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.215 · Cited by 162
Expression of CD44 in human lung tumors
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92213-6 · Cited by 161
A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen
Schietinger, A., Philip, M., Yoshida, B. A., Azadi, P., Liu, H., Meredith, S. C., & Schreiber, H. (2006) · Science · doi:10.1126/science.1129200 · Cited by 160
張, 秀. (2014) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · doi:10.1016/j.canlet · Cited by 160
Iwai, T., Kudo, T., Kawamoto, R., Kubota, T., Togayachi, A., Hiruma, T., Okada, T., Kawamoto, T., Morozumi, K., & Narimatsu, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407983102 · Cited by 159
Lock, K., Zhang, J., Lu, J., Lee, S. H., & Crocker, P. R. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.04.007 · Cited by 158
Miyazaki, K., Ohmori, K., Izawa, M., Koike, T., Kumamoto, K., Furukawa, K., Ando, T., Kiso, M., Yamaji, T., Hashimoto, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3614 · Cited by 158
Läubli, H., Stevenson, J. L., Varki, A., Varki, N. M., & Borsig, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3121 · Cited by 158
Self-citationP-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation
Guyer, D., Moore, K., Lynam, E. B., Schammel, C., Rogelj, S., McEver, R., & Sklar, L. A. (1996) · Blood · doi:10.1182/blood.v88.7.2415.bloodjournal8872415 · Cited by 158
Shimodaira, K., Nakayama, J., Nakamura, N., Hasebe, O., Katsuyama, T., & Fukuda, M. (1997) · PubMed · Cited by 155
Mechanisms of cancer-associated glycosylation changes
Dall’Olio, F., Malagolini, N., Trinchera, M., & Chiricolo, M. (2011) · Frontiers in bioscience · doi:10.2741/3951 · Cited by 154
Campbell, B. J., Finnie, I. A., Hounsell, E. F., & Rhodes, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117700 · Cited by 152
Blood Group Precursor T-Antigen Expression in Human Urinary Bladder Carcinoma
Coon, J. S., Weinstein, R. S., & Summers, J. L. (1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/77.6.692 · Cited by 151
Olio, F. D., Malagolini, N., Stefano, G. D., et al. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440309 · Cited by 150
Tremblay, P.-L., Auger, F. A., & Huot, J. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209664 · Cited by 147
Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping.
Drexler, H. G. (1987) · PubMed · Cited by 146
ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues
Reis, C. A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e345 · Cited by 142
Nath, Hartnell, Happerfield, Miles, Burchell, J., Taylor‐Papadimitriou, & Crocker, P. R. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00827.x · Cited by 142
The selectin–selectin ligand axis in tumor progression
Witz, I. P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9101-z · Cited by 142
Ohnishi, K., Komohara, Y., Saito, Y., Miyamoto, Y., Watanabe, M., Baba, H., & Takeya, M. (2013) · Cancer Science · doi:10.1111/cas.12212 · Cited by 141
Over-expression of ST3Gal-I promotes mammary tumorigenesis
Picco, G., Julien, S., Brockhausen, I., Beatson, R., Antonopoulos, A., Haslam, S. M., Mandel, U., Dell, A., Pinder, S. E., Taylor‐Papadimitriou, J., et al. (2010) · Glycobiology · doi:10.1093/glycob/cwq085 · Cited by 138
CD44 on LS174T Colon Carcinoma Cells Possesses E-Selectin Ligand Activity
Hanley, W. D., Burdick, M. M., Κωνσταντόπουλος, Κ., & Sackstein, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4557 · Cited by 135
Galectin-1 Binds Different CD43 Glycoforms to Cluster CD43 and Regulate T Cell Death
Hernandez, J. D., Nguyen, J. T., He, J., Wang, W., Ardman, B. M., Green, J. M., Fukuda, M., & Baum, L. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5328 · Cited by 133
Izumi, Y., Taniuchi, Y., Tsuji, T., et al. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1027 · Cited by 133
Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
Banh, A., Zhang, J., Cao, H., Bouley, D. M., Kwok, S., Kong, C. S., Giaccia, A. J., Koong, A. C., & Le, Q. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4157 · Cited by 133
Yamashiro, S., Takeya, M., Nishi, T., Kuratsu, J. I., Yoshimura, T., Ushio, Y., & Takahashi, K. (1994) · PubMed Central · Cited by 132
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Ito, K., Stannard, K. A., Gabutero, E., Clark, A. M., Neo, S., Onturk, S., Blanchard, H., & Ralph, S. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9388-2 · Cited by 132
KOBAYASHI, K. P., Matsumoto, S., Morishima, T., Kawabe, T., & Okamoto, T. (2000) · PubMed · Cited by 132
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking
Barthel, S. R., Wiese, G. K., Cho, J., Opperman, M. J., Hays, D. L., Siddiqui, J., Pienta, K. J., Furie, B., & Dimitroff, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906074106 · Cited by 127
Dimitroff, C. J., Descheny, L., Trujillo, N., Kim, R., Nguyen, V., Huang, W. Z., Pienta, K. J., Kutok, J. L., & Rubin, M. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4653 · Cited by 127
Jørgensen, T. L., Berner, A., Kaalhus, O., Tveter, K. J., Danielsen, H. E., & Bryne, M. (1995) · PubMed · Cited by 125
Variant isoforms of CD44 are P‐ and L‐selectin ligands on colon carcinoma cells
Hanley, W. D., Napier, S. L., Burdick, M. M., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-4574fje · Cited by 119
Burdick, M. M., McCaffery, J. M., Kim, Y. S., Bochner, B. S., & Κωνσταντόπουλος, Κ. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00423.2002 · Cited by 117
Geßner, P., Riedl, S., Quentmaier, A., et al. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90056-f · Cited by 115
Schneider, F., Kemmner, W., Haensch, W., Franke, G., Gretschel, S., Karsten, U. R., & Schlag, P. M. (2001) · PubMed · Cited by 113
Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs
Ando, M., Tu, W., Nishijima, K.-I., & Iijima, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.111 · Cited by 112
Kumamoto, K., Goto, Y., Sekikawa, K., Takenoshita, S., Ishida, N., Kawakita, M., & Kannagi, R. (2001) · PubMed · Cited by 112
Krishnan, V., Bane, S. M., Kawle, P. D., Naresh, K. N., & Kalraiya, R. D. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2036-2 · Cited by 110
Tsuchida, A., Okajima, T., Furukawa, K., Ando, T., Ishida, H., Yoshida, A., Nakamura, Y., Kannagi, R., Kiso, M., & Furukawa, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211034200 · Cited by 107
Conze, T., Carvalho, A. S., Landegren, U. D., Almeida, R., Reis, C. A., David, L., & Söderberg, O. (2009) · Glycobiology · doi:10.1093/glycob/cwp161 · Cited by 107
HCELL Is the Major E- and L-selectin Ligand Expressed on LS174T Colon Carcinoma Cells
Burdick, M. M., Chu, J. T., Godár, S., & Sackstein, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513617200 · Cited by 105
VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice
Ferjancic, S., Gil‐Bernabé, A. M., Hill, S. A., Allen, P. D., Richardson, P., Sparey, T. J., Savory, E., McGuffog, J., & Muschel, R. J. (2013) · Blood · doi:10.1182/blood-2012-08-449819 · Cited by 104
Gout, S., Morin, C., Houle, F., & Huot, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4605 · Cited by 104
Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
Jandus, C., Simon, H., & von Gunten, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.018 · Cited by 103
Chen, L., Zhang, W., Fregien, N., & Pierce, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202124 · Cited by 102
CD33‐related siglecs as potential modulators of inflammatory responses
Crocker, P. R., McMillan, S. J., & Richards, H. E. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06449.x · Cited by 102
Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins
Taverna, D., Moher, H., Crowley, D. G., Borsig, L., Varki, A. P., & Hynes, R. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307289101 · Cited by 101
Self-citationKannagi, R., Sakuma, K., Miyazaki, K., Lim, K., Yusa, A., Yin, J., & Izawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01455.x · Cited by 100
Kuo, P.-L., Hung, J., Huang, S.-K., Chou, S., Cheng, D.-E., Jong, Y., Hung, C., Yang, C., Tsai, Y., Hsu, Y.-L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002940 · Cited by 98
Sawada, M., Moriya, S., Saito, S., Shineha, R., Satomi, S., Yamori, T., Tsuruo, T., Kannagi, R., & Miyagi, T. (2001) · International Journal of Cancer · doi:10.1002/ijc.1598 · Cited by 96
Weston, B. W., Hiller, K. M., Mayben, J. P., Manousos, G. A., Bendt, K. M., Liu, R., & Cusack, J. C. (1999) · PubMed · Cited by 96
Miyazaki, K., Sakuma, K., Kawamura, Y. I., Izawa, M., Ohmori, K., Mitsuki, M., Yamaji, T., Hashimoto, Y., Suzuki, A., Saitō, Y., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100605 · Cited by 95
Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model
Julien, S., Picco, G., Sewell, R., Vercoutter‐Edouart, A., Tarp, M. S., Miles, D. W., Clausen, H., Taylor-Papadimitriou, J., & Burchell, J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605083 · Cited by 94
Harada, N., Mizoi, T., Kinouchi, M., Hoshi, K., Ishii, S., Shiiba, K.-I., Sasaki, I., & Matsuno, S. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<67::aid-ijc1011>3.0.co;2-d · Cited by 93
Kawasaki, Y., Ito, A., Withers, D. A., Taima, T., Kakoi, N., Saito, S., & Arai, Y. (2010) · Glycobiology · doi:10.1093/glycob/cwq116 · Cited by 93
Guo, H., Randolph, M. E., & Pierce, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611518200 · Cited by 86
Selectins as Mediators of Lung Metastasis
Laubli, H. P., & Borsig, L. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0043-6 · Cited by 85
Self-citationDefinition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation
Barthel, S. R., Hays, D. L., Yazawa, E. M., Opperman, M. J., Walley, K. C., Nimrichter, L., Burdick, M. M., Gillard, B. M., Moser, M. T., Pantel, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3264 · Cited by 84
Julien, S., Krzewinski‐Recchi, M., Harduin‐Lepers, A., Gouyer, V., Huet, G., Bourhis, X. L., & Delannoy, P. (2001) · Glycoconjugate Journal · doi:10.1023/a:1022200525695 · Cited by 83
Ibrahim, N. K., Murray, J. L., Zhou, D., Mittendorf, E. A., Sample, D., Tautchin, M., & Miles, D. W. (2013) · Journal of Cancer · doi:10.7150/jca.7028 · Cited by 82
Thomas, S. N., Schnaar, R. L., & Κωνσταντόπουλος, Κ. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00472.2008 · Cited by 82
CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
Rall, C., & Rustgi, A. K. (1995) · PubMed · Cited by 82
Tanida, S., Akita, K., Ishida, A., Mori, Y., Toda, M., Inoue, M., Ohta, M., Yashiro, M., Sawada, T., Hirakawa, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.471318 · Cited by 81
The immunoregulatory glycan‐binding protein galectin‐1 triggers human platelet activation
Pacienza, N., Pozner, R. G., Bianco, G. A., D’Atri, L. P., Croci, D. O., Negrotto, S., Malaver, E., Gomez, R. M., Rabinovich, G. A., & Schattner, M. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-9524com · Cited by 81
Singh, R., Campbell, B. J., Yu, L., Fernig, D. G., Milton, J. D., Goodlad, R. A., Fitzgerald, A. J., & Rhodes, J. M. (2001) · Glycobiology · doi:10.1093/glycob/11.7.587 · Cited by 80
Jadhav, S., Bochner, B. S., & Κωνσταντόπουλος, Κ. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5986 · Cited by 80
Ozaki, H., Matsuzaki, H., Ando, H., Kaji, H., Nakanishi, H., Ikehara, Y., & Narimatsu, H. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9445-1 · Cited by 78
High serum galectin-3 in advanced melanoma: preliminary results.
Vereecken, P. M., Boudjeltia, K. Z., Debray, C., Awada, A. H., Legssyer, I., Salès, F., Pétein, M., Vanhaeverbeek, M., Ghanem, G., & Heenen, M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01992.x · Cited by 77
Human fucosyltransferase 6 enables prostate cancer metastasis to bone
Li, J., de Guillebon, A., Hsu, J.-W., Barthel, S. R., Dimitroff, C. J., Lee, Y., & King, M. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.690 · Cited by 77
Ogawa, J., Inoue, H., & Koide, S. (1996) · PubMed · Cited by 72
Clément, M., Rocher, J., Loirand, G., & LePendu, J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01350 · Cited by 70
Reeder, J. A., Gotley, D. C., Walsh, M. D., et al. (1998) · PubMed · Cited by 69
Davidson, B., Gotlieb, W. H., Ben‐Baruch, G., Kopolovic, J., Goldberg, I., Nesland, J. M., Berner, A., Bjåmer, A., & Bryne, M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5708 · Cited by 63
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“The role of selectin interactions in a variety of normal and pathological conditions like inflammation and cancer is now understood (309, (916) (917) (918) (919) (920) (921) , and therapeutic approaches are in evaluation (921) (922) (923) .”
BackgroundProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 551
Hallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
Sialic acids sweeten a tumor's life
Büll, C., Stoel, M. A., den Brok, M. H., & Adema, G. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0728 · Cited by 496
Metadata
- Authors
- Häuselmann, I., & Borsig, L.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 4
- Pages
- 28-28
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2134294354
- Cited by
- 382
- References
- 219
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.